Details for New Drug Application (NDA): 020941

✉ Email this page to a colleague

NDA 020941 describes ABREVA, which is a drug marketed by Haleon Us Holdings and is included in one NDA. It is available from one supplier. Additional details are available on the ABREVA profile page.

The generic ingredient in ABREVA is docosanol. There are five drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the docosanol profile page.

Summary for 020941

Tradename:	ABREVA
Applicant:	Haleon Us Holdings
Ingredient:	docosanol
Patents:	0

Suppliers and Packaging for NDA: 020941

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ABREVA	docosanol	CREAM;TOPICAL	020941	NDA	Haleon US Holdings LLC	0135-0200	0135-0200-01	2 g in 1 TUBE (0135-0200-01)
ABREVA	docosanol	CREAM;TOPICAL	020941	NDA	Haleon US Holdings LLC	0135-0200	0135-0200-03	2 g in 1 BOTTLE, PUMP (0135-0200-03)

Profile for product number 001

Active Rx/OTC/Discontinued:	OTC	Dosage:	CREAM;TOPICAL			Strength	10%
Approval Date:	Jul 25, 2000	TE:		RLD:	Yes

Expired US Patents for NDA 020941

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Haleon Us Holdings	ABREVA	docosanol	CREAM;TOPICAL	020941-001	Jul 25, 2000	⤷ Get Started Free	⤷ Get Started Free
Haleon Us Holdings	ABREVA	docosanol	CREAM;TOPICAL	020941-001	Jul 25, 2000	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.